Consultative and Perioperative Medicine — MCQs

Q: A 45-year-old woman with Child-Pugh Class B cirrhosis requires urgent abdominal surgery. Preoperative labs show: Albumin 2.8 g/dL, Bilirubin 3.2 mg/dL, INR 1.9, Creatinine 1.1 mg/dL. Her MELD score is calculated as 18. What is the approximate 90-day mortality risk?

25-30%. ***25-30%*** - The **MELD score** (Model for End-Stage Liver Disease) is a validated predictor of **90-day mortality** in patients with cirrhosis undergoing major abdominal surgery [1]. - A **MELD score of 15-20** (this patient is 18) typically correlates with a post-operative mortality risk in the **25-30% range**. *5-10%* - This range is associated with **Child-Pugh Class A** or **MELD scores 20** or those with **Child-Pugh Class C** cirrhosis. - Surgical intervention in this group is often avoided unless it is life-saving due to the high risk of **liver failure** and **death** post-operatively. *15-20%* - This range often corresponds to patients with a **MELD score of 10-15** or compensated **Child-Pugh Class B** cirrhosis. - While the risk is significant, it is lower than the mortality predicted for a patient with a score of 18 and signs of **coagulopathy** (INR 1.9) [1].

Q: A 65-year-old man with mechanical aortic valve on warfarin (INR 2.8) requires elective cholecystectomy. What is the most appropriate perioperative anticoagulation management?

Stop warfarin 5 days before, bridge with therapeutic LMWH. Warfarin should be stopped **5 days preoperatively** to allow the INR to normalize, while **therapeutic-dose LMWH** is started once the INR drops below the therapeutic range [1]. *Stop warfarin 3 days before, bridge with unfractionated heparin infusion* - Stopping warfarin only **3 days before** surgery is often insufficient time for the **INR to reach <1.5**, increasing the risk of surgical bleeding [1]. - While **Unfractionated Heparin (UFH)** is an option, it requires hospitalization for IV administration, making **LMWH** the preferred choice for convenience in elective outpatient settings. *Continue warfarin throughout surgery* - Continuing warfarin is contraindicated for major abdominal surgeries like **cholecystectomy** due to the high risk of **intraoperative bleeding**. - This approach is typically reserved only for minor procedures with low bleeding risk, such as **minor dental or skin surgeries**. *Stop warfarin 5 days before, no bridging therapy* - Omitting bridging therapy is appropriate for low-risk patients, but this patient has a **mechanical heart valve**, which carries a high **thromboembolic risk**. - Failure to bridge in this population significantly increases the likelihood of **valvular thrombosis** or a **systemic embolic event** during the perioperative subtherapeutic window.

Q: How does tranexamic acid reduce perioperative blood loss in major surgery?

By inhibiting plasminogen activation. ***By inhibiting plasminogen activation*** - **Tranexamic acid** is a synthetic derivative of the amino acid lysine that acts as a competitive inhibitor of **plasminogen activation**. - By binding to the lysine-binding sites on plasminogen, it prevents its conversion to **plasmin**, thereby inhibiting **fibrinolysis** and preserving the clot integrity. *By activating Factor VII* - Factor VII activation is part of the **extrinsic pathway** of the coagulation cascade; agents like **recombinant activated Factor VII (rFVIIa)** work via this mechanism, not tranexamic acid. - Supporting the coagulation cascade is distinct from inhibiting the breakdown of existing clots through **antifibrinolytics**. *By promoting platelet aggregation* - Platelet aggregation is primarily mediated by substances like **ADP**, **thromboxane A2**, and **von Willebrand factor**, rather than tranexamic acid. - While essential for **primary hemostasis**, tranexamic acid does not directly stimulate platelet receptors or aggregation pathways. *By stabilizing fibrinogen* - Fibrinogen is the precursor to fibrin; while tranexamic acid helps preserve the **fibrin mesh**, it does not chemically stabilize the fibrinogen molecule itself. - Stabilization of the **fibrin polymer** is typically the role of **Factor XIII**, which creates cross-links to strengthen the definitive clot.

Q: What is the minimum recommended duration to withhold aspirin before elective non-cardiac surgery in patients without coronary stents?

7 days. ***7 days*** - For elective **non-cardiac surgery** in patients without coronary stents, aspirin should be withheld for at least **7 days** to allow for the recovery of a sufficient population of **platelets** with normal function. - This timeframe is based on the **irreversible inhibition** of cyclooxygenase-1 (COX-1) and the approximately 10-day **lifespan of a platelet**, ensuring adequate hemostasis during the procedure. *10 days* - While 10 days covers the entire lifespan of a **platelet**, it is longer than the minimum clinical requirement for **adequate hemostasis** in most surgical cases. - Most guidelines prioritize a **7-day window** as balanced and sufficient for reducing **perioperative bleeding** risk. *3 days* - This duration is insufficient because only approximately **30% of platelets** would be replaced, leaving a significant risk of **antiplatelet-induced bleeding** during surgery. - **Incomplete recovery** of platelet function at 3 days can lead to complications in procedures requiring strict **hemostatic control**. *5 days* - While 5 days allows for some **platelet turnover**, it may not provide a safe margin for high-risk elective surgeries compared to the standard **7-day recommendation**. - Certain guidelines for other drugs like **warfarin** or **clopidogrel** may use this window, but for **aspirin**, 7 days remains the primary recommendation for total recovery.

Q: Which risk assessment tool is recommended by the American College of Cardiology/American Heart Association for preoperative cardiac evaluation?

Revised Cardiac Risk Index (RCRI). ***Revised Cardiac Risk Index (RCRI)*** - The **RCRI** (or Lee's Index) is the standard tool recommended by the **ACC/AHA** guidelines to estimate the risk of **perioperative major adverse cardiac events (MACE)**. - It utilizes six independent predictors: **high-risk surgery**, ischemic heart disease, **congestive heart failure**, cerebrovascular disease, **insulin-dependent diabetes**, and serum creatinine >2.0 mg/dL. *Goldman Cardiac Risk Index* - This was the **original multifactorial clinical index** developed in 1977, but it has largely been replaced in modern practice by the updated RCRI. - It included factors like **S3 gallop** and **jugular venous distention**, which are more difficult to standardize than the criteria used in the RCRI. *Gupta Myocardial Infarction or Cardiac Arrest Calculator* - The **Gupta Calculator** (based on the NSQIP database) is a valid alternative but is not the primary clinical tool specifically emphasized in traditional **ACC/AHA preoperative guidelines**. - While it offers higher predictive accuracy for **perioperative MI**, it requires a web-based interface and includes **functional status** as a key variable. *Detsky Modified Multifactorial Index* - This index is a **modification of the Goldman Index** that includes variables like **angina class** and remote history of myocardial infarction. - It is utilized less frequently than the RCRI because it is more complex to calculate and has not shown superior **predictive value** in broad surgical populations.

Consultative and Perioperative Medicine — MCQs

A 62-year-old man with drug-eluting stent placed 4 months ago requires urgent colonoscopy with polypectomy for a bleeding polyp. He is on dual antiplatelet therapy (aspirin and clopidogrel). Analysis of risks shows continued bleeding risk versus stent thrombosis risk. What is the most evidence-based management strategy?

A 72-year-old man develops postoperative delirium on day 2 after hip replacement. His vitals are stable, and examination is unremarkable except for confusion. Laboratory workup including CBC, electrolytes, and arterial blood gas is normal. What is the most likely precipitating factor?

A 45-year-old woman with Child-Pugh Class B cirrhosis requires urgent abdominal surgery. Preoperative labs show: Albumin 2.8 g/dL, Bilirubin 3.2 mg/dL, INR 1.9, Creatinine 1.1 mg/dL. Her MELD score is calculated as 18. What is the approximate 90-day mortality risk?

A 58-year-old diabetic patient on metformin is scheduled for CT scan with iodinated contrast. His serum creatinine is 1.8 mg/dL and eGFR is 42 mL/min/1.73m². What is the most appropriate management of metformin?

A 65-year-old man with mechanical aortic valve on warfarin (INR 2.8) requires elective cholecystectomy. What is the most appropriate perioperative anticoagulation management?

How does tranexamic acid reduce perioperative blood loss in major surgery?

Why is perioperative beta-blocker initiation not routinely recommended in patients undergoing non-cardiac surgery?

What is the minimum recommended duration to withhold aspirin before elective non-cardiac surgery in patients without coronary stents?

Q10

Which risk assessment tool is recommended by the American College of Cardiology/American Heart Association for preoperative cardiac evaluation?

Consultative and Perioperative Medicine Indian Medical PG Practice Questions and MCQs

Question 1: A hospital is implementing a protocol to reduce perioperative pulmonary complications in high-risk patients undergoing major abdominal surgery. Based on current evidence, which combination of interventions would provide the greatest benefit?

A. Preoperative spirometry, postoperative incentive spirometry, early mobilization
B. Smoking cessation >8 weeks prior, lung expansion maneuvers, epidural analgesia (Correct Answer)
C. Prophylactic bronchodilators, routine chest physiotherapy, supplemental oxygen
D. Preoperative antibiotics, deep breathing exercises, prolonged mechanical ventilation

Explanation: ***Smoking cessation >8 weeks prior, lung expansion maneuvers, epidural analgesia*** - **Smoking cessation** must occur at least **8 weeks** before surgery to effectively reduce the risk of pulmonary complications to baseline levels; shorter periods may actually increase secretion production [1]. - **Epidural analgesia** provides superior pain control for abdominal surgery, which facilitates better **respiratory effort** and prevents the diaphragm dysfunction that leads to atelectasis. *Preoperative spirometry, postoperative incentive spirometry, early mobilization* - While early mobilization is beneficial, **preoperative spirometry** is a diagnostic tool used for **risk stratification** rather than an intervention that actively reduces postoperative complications. - **Incentive spirometry** alone is generally not superior to deep breathing exercises and must be part of a broader lung expansion protocol to be effective. *Prophylactic bronchodilators, routine chest physiotherapy, supplemental oxygen* - **Prophylactic bronchodilators** are not recommended for all patients and should only be used in patients with specific underlying conditions like **COPD** or **Asthma** [1]. - **Routine chest physiotherapy** has not consistently demonstrated a significant reduction in **postoperative pulmonary complications (PPCs)** for general high-risk abdominal surgery patients. *Preoperative antibiotics, deep breathing exercises, prolonged mechanical ventilation* - **Prolonged mechanical ventilation** is actually a risk factor for **ventilator-associated pneumonia** and other lung injuries, rather than a preventive strategy [2]. - While **deep breathing exercises** are helpful, they are outweighed here by the risks associated with unnecessary mechanical ventilation and the lack of systemic evidence for routine **preoperative antibiotics** specifically for PPC prevention [3].

Question 2: A 62-year-old man with drug-eluting stent placed 4 months ago requires urgent colonoscopy with polypectomy for a bleeding polyp. He is on dual antiplatelet therapy (aspirin and clopidogrel). Analysis of risks shows continued bleeding risk versus stent thrombosis risk. What is the most evidence-based management strategy?

A. Discontinue clopidogrel only, add prophylactic heparin bridging
B. Discontinue both aspirin and clopidogrel 7 days before procedure
C. Continue aspirin, discontinue clopidogrel 5 days before procedure (Correct Answer)
D. Continue both aspirin and clopidogrel throughout procedure

Explanation: ***Continue aspirin, discontinue clopidogrel 5 days before procedure*** - In patients with a **coronary stent** implanted recently, maintaining **aspirin monotherapy** provides essential protection against **stent thrombosis** while reducing the procedural bleeding risk compared to dual therapy [1]. - For high-bleeding-risk procedures like **polypectomy**, guidelines recommend pausing **P2Y12 inhibitors** (clopidogrel) for **5 days** to allow platelet function to recover sufficiently. *Discontinue clopidogrel only, add prophylactic heparin bridging* - **Heparin bridging** is indicated for patients at high risk of **thromboembolism** (e.g., mechanical valves or AFib) but has no proven benefit in preventing **stent thrombosis**. - Utilizing heparin in place of antiplatelets increases **bleeding complications** without addressing the pathophysiology of platelet-induced stent occlusion. *Discontinue both aspirin and clopidogrel 7 days before procedure* - Complete cessation of **dual antiplatelet therapy (DAPT)** within the first 6-12 months of a **drug-eluting stent (DES)** severely increases the risk of **major adverse cardiovascular events (MACE)**. - Aspirin should almost always be continued perioperatively unless the procedure involves a closed-space surgery with a high risk of catastrophic bleeding, such as **neurosurgery**. *Continue both aspirin and clopidogrel throughout procedure* - While this strategy eliminates the risk of **stent thrombosis**, it significantly increases the risk of **post-polypectomy bleeding**, which can be difficult to manage during the procedure. - Current evidence-based surgical guidelines categorize **colonoscopic polypectomy** as a **high-bleeding-risk** procedure that mandates the temporary interruption of clopidogrel.

Question 3: A 72-year-old man develops postoperative delirium on day 2 after hip replacement. His vitals are stable, and examination is unremarkable except for confusion. Laboratory workup including CBC, electrolytes, and arterial blood gas is normal. What is the most likely precipitating factor?

A. Undiagnosed dementia with acute decompensation
B. Hypoxia from subclinical pulmonary embolism
C. Multifactorial including surgery, medications, and environmental factors (Correct Answer)
D. Occult infection not yet manifested

Explanation: Multifactorial including surgery, medications, and environmental factors - Postoperative **delirium** in elderly patients is most commonly triggered by a combination of **surgical stress**, **anesthesia**, and use of **opioid** or **anticholinergic** medications [1]. - The **unfamiliar environment** of the hospital, **sleep deprivation**, and **immobilization** post-surgery further exacerbate cognitive dysfunction in vulnerable individuals [1]. *Undiagnosed dementia with acute decompensation* - While **dementia** is a significant **predisposing factor** for delirium, it describes the baseline vulnerability rather than the acute trigger [1]. - In this clinical scenario, the delirium occurs on postoperative day 2, pointing toward the **perioperative stressors** as the primary precipitant [1]. *Hypoxia from subclinical pulmonary embolism* - A normal **arterial blood gas (ABG)** and stable vital signs effectively rule out **hypoxia** or significant **pulmonary embolism** as the cause [1]. - While PE is a concern after hip replacement, medical workup shows no **respiratory distress** or oxygenation issues to explain the confusion. *Occult infection not yet manifested* - The laboratory workup, including a normal **CBC**, makes an acute infectious process like **sepsis** or a **urinary tract infection** unlikely [1]. - While infection is a known cause of delirium, the absence of **fever**, **leukocytosis**, or vital sign instability directs the diagnosis toward non-infectious perioperative factors [1].

Question 4: A 45-year-old woman with Child-Pugh Class B cirrhosis requires urgent abdominal surgery. Preoperative labs show: Albumin 2.8 g/dL, Bilirubin 3.2 mg/dL, INR 1.9, Creatinine 1.1 mg/dL. Her MELD score is calculated as 18. What is the approximate 90-day mortality risk?

A. 5-10%
B. 40-50%
C. 15-20%
D. 25-30% (Correct Answer)

Explanation: ***25-30%*** - The **MELD score** (Model for End-Stage Liver Disease) is a validated predictor of **90-day mortality** in patients with cirrhosis undergoing major abdominal surgery [1]. - A **MELD score of 15-20** (this patient is 18) typically correlates with a post-operative mortality risk in the **25-30% range**. *5-10%* - This range is associated with **Child-Pugh Class A** or **MELD scores <10**, representing much lower perioperative risk. - Patients with such low scores have preserved **synthetic liver function** and minimal portal hypertension. *40-50%* - This elevated mortality risk is generally seen in patients with **MELD scores >20** or those with **Child-Pugh Class C** cirrhosis. - Surgical intervention in this group is often avoided unless it is life-saving due to the high risk of **liver failure** and **death** post-operatively. *15-20%* - This range often corresponds to patients with a **MELD score of 10-15** or compensated **Child-Pugh Class B** cirrhosis. - While the risk is significant, it is lower than the mortality predicted for a patient with a score of 18 and signs of **coagulopathy** (INR 1.9) [1].

Question 5: A 58-year-old diabetic patient on metformin is scheduled for CT scan with iodinated contrast. His serum creatinine is 1.8 mg/dL and eGFR is 42 mL/min/1.73m². What is the most appropriate management of metformin?

A. Reduce metformin dose by 50% for 3 days
B. Continue metformin and ensure adequate hydration
C. Hold metformin on day of procedure, restart after 48 hours with normal renal function (Correct Answer)
D. Stop metformin permanently and switch to insulin

Explanation: ***Hold metformin on day of procedure, restart after 48 hours with normal renal function*** - In patients with an **eGFR between 30-60 mL/min/1.73m²**, metformin must be withheld at the time of the procedure to mitigate the risk of **lactic acidosis** if contrast-induced nephropathy occurs. - Metformin should only be restarted **48 hours later** once serum creatinine has been re-evaluated and confirmed to be stable [1]. *Reduce metformin dose by 50% for 3 days* - Dose reduction is not the standard protocol; the drug must be **completely withheld** to prevent the accumulation of metformin in the setting of potential acute kidney injury. - This approach does not sufficiently protect the patient from the risk of **metformin-associated lactic acidosis (MALA)**. *Continue metformin and ensure adequate hydration* - While **hydration** is essential to prevent contrast-induced nephropathy, continuing metformin in a patient with an **eGFR <60** is contraindicated during radiocontrast administration. - Metformin is primarily **renally excreted**, and any transient decline in renal function could lead to dangerous systemic levels [1]. *Stop metformin permanently and switch to insulin* - **Permanent cessation** is unnecessary as the patient's eGFR (42 mL/min) is still above the absolute contraindication threshold for metformin (eGFR <30 mL/min) [2]. - Metformin remains a first-line therapy for Type 2 Diabetes; the interruption is only **temporary** to ensure safety during the peri-procedure period [2].

Question 6: A 65-year-old man with mechanical aortic valve on warfarin (INR 2.8) requires elective cholecystectomy. What is the most appropriate perioperative anticoagulation management?

A. Stop warfarin 3 days before, bridge with unfractionated heparin infusion
B. Continue warfarin throughout surgery
C. Stop warfarin 5 days before, bridge with therapeutic LMWH (Correct Answer)
D. Stop warfarin 5 days before, no bridging therapy

Explanation: Warfarin should be stopped **5 days preoperatively** to allow the INR to normalize, while **therapeutic-dose LMWH** is started once the INR drops below the therapeutic range [1]. *Stop warfarin 3 days before, bridge with unfractionated heparin infusion* - Stopping warfarin only **3 days before** surgery is often insufficient time for the **INR to reach <1.5**, increasing the risk of surgical bleeding [1]. - While **Unfractionated Heparin (UFH)** is an option, it requires hospitalization for IV administration, making **LMWH** the preferred choice for convenience in elective outpatient settings. *Continue warfarin throughout surgery* - Continuing warfarin is contraindicated for major abdominal surgeries like **cholecystectomy** due to the high risk of **intraoperative bleeding**. - This approach is typically reserved only for minor procedures with low bleeding risk, such as **minor dental or skin surgeries**. *Stop warfarin 5 days before, no bridging therapy* - Omitting bridging therapy is appropriate for low-risk patients, but this patient has a **mechanical heart valve**, which carries a high **thromboembolic risk**. - Failure to bridge in this population significantly increases the likelihood of **valvular thrombosis** or a **systemic embolic event** during the perioperative subtherapeutic window.

Question 7: How does tranexamic acid reduce perioperative blood loss in major surgery?

A. By activating Factor VII
B. By inhibiting plasminogen activation (Correct Answer)
C. By promoting platelet aggregation
D. By stabilizing fibrinogen

Explanation: ***By inhibiting plasminogen activation*** - **Tranexamic acid** is a synthetic derivative of the amino acid lysine that acts as a competitive inhibitor of **plasminogen activation**. - By binding to the lysine-binding sites on plasminogen, it prevents its conversion to **plasmin**, thereby inhibiting **fibrinolysis** and preserving the clot integrity. *By activating Factor VII* - Factor VII activation is part of the **extrinsic pathway** of the coagulation cascade; agents like **recombinant activated Factor VII (rFVIIa)** work via this mechanism, not tranexamic acid. - Supporting the coagulation cascade is distinct from inhibiting the breakdown of existing clots through **antifibrinolytics**. *By promoting platelet aggregation* - Platelet aggregation is primarily mediated by substances like **ADP**, **thromboxane A2**, and **von Willebrand factor**, rather than tranexamic acid. - While essential for **primary hemostasis**, tranexamic acid does not directly stimulate platelet receptors or aggregation pathways. *By stabilizing fibrinogen* - Fibrinogen is the precursor to fibrin; while tranexamic acid helps preserve the **fibrin mesh**, it does not chemically stabilize the fibrinogen molecule itself. - Stabilization of the **fibrin polymer** is typically the role of **Factor XIII**, which creates cross-links to strengthen the definitive clot.

Question 8: Why is perioperative beta-blocker initiation not routinely recommended in patients undergoing non-cardiac surgery?

A. Lack of cardiovascular benefit
B. Increased risk of stroke and mortality (Correct Answer)
C. Poor patient compliance
D. Increased risk of myocardial infarction

Explanation: Detailed clinical evidence, particularly from the POISE trial, suggests that the perioperative initiation of beta-blockers immediately before non-cardiac surgery increases risks such as stroke and all-cause mortality, though it provides some protection against myocardial infarction. Current management guidelines emphasize that while antihypertensive therapy aims to reduce adverse cardiovascular events like stroke and coronary artery disease [1], the specific safety profile in the perioperative setting requires caution due to potential hypotension and bradycardia; in certain critical contexts, such as heart failure or hypotension (systolic BP < 105 mmHg), beta-blockers should be avoided altogether [2]. ***Increased risk of stroke and mortality*** - Evidence from the **POISE trial** showed that starting **beta-blockers** immediately before non-cardiac surgery increases the risk of **stroke** and **all-cause mortality**. - This is likely due to perioperative **hypotension** and **bradycardia** which compromise cerebral perfusion during the surgical stress response. *Lack of cardiovascular benefit* - Beta-blockers actually provide a significant benefit by reducing the incidence of **perioperative myocardial infarction**. - The recommendation against routine initiation is based on the **safety profile**, not a lack of efficacy in protecting the heart. *Poor patient compliance* - Compliance is not the primary factor in **perioperative initiation**, as the medication is typically administered by clinical staff in a controlled setting. - The clinical guidelines are driven by **adverse outcomes** and data from randomized controlled trials rather than patient adherence issues. *Increased risk of myocardial infarction* - Perioperative beta-blocker initiation actually **decreases** the risk of **non-fatal myocardial infarction** by limiting tachycardia. - Despite this protective effect on the myocardium, the increased risks of **death and stroke** outweigh the benefit of preventing MI.

Question 9: What is the minimum recommended duration to withhold aspirin before elective non-cardiac surgery in patients without coronary stents?

A. 10 days
B. 3 days
C. 5 days
D. 7 days (Correct Answer)

Explanation: ***7 days*** - For elective **non-cardiac surgery** in patients without coronary stents, aspirin should be withheld for at least **7 days** to allow for the recovery of a sufficient population of **platelets** with normal function. - This timeframe is based on the **irreversible inhibition** of cyclooxygenase-1 (COX-1) and the approximately 10-day **lifespan of a platelet**, ensuring adequate hemostasis during the procedure. *10 days* - While 10 days covers the entire lifespan of a **platelet**, it is longer than the minimum clinical requirement for **adequate hemostasis** in most surgical cases. - Most guidelines prioritize a **7-day window** as balanced and sufficient for reducing **perioperative bleeding** risk. *3 days* - This duration is insufficient because only approximately **30% of platelets** would be replaced, leaving a significant risk of **antiplatelet-induced bleeding** during surgery. - **Incomplete recovery** of platelet function at 3 days can lead to complications in procedures requiring strict **hemostatic control**. *5 days* - While 5 days allows for some **platelet turnover**, it may not provide a safe margin for high-risk elective surgeries compared to the standard **7-day recommendation**. - Certain guidelines for other drugs like **warfarin** or **clopidogrel** may use this window, but for **aspirin**, 7 days remains the primary recommendation for total recovery.

Question 10: Which risk assessment tool is recommended by the American College of Cardiology/American Heart Association for preoperative cardiac evaluation?

A. Goldman Cardiac Risk Index
B. Gupta Myocardial Infarction or Cardiac Arrest Calculator
C. Revised Cardiac Risk Index (RCRI) (Correct Answer)
D. Detsky Modified Multifactorial Index

Explanation: ***Revised Cardiac Risk Index (RCRI)*** - The **RCRI** (or Lee's Index) is the standard tool recommended by the **ACC/AHA** guidelines to estimate the risk of **perioperative major adverse cardiac events (MACE)**. - It utilizes six independent predictors: **high-risk surgery**, ischemic heart disease, **congestive heart failure**, cerebrovascular disease, **insulin-dependent diabetes**, and serum creatinine >2.0 mg/dL. *Goldman Cardiac Risk Index* - This was the **original multifactorial clinical index** developed in 1977, but it has largely been replaced in modern practice by the updated RCRI. - It included factors like **S3 gallop** and **jugular venous distention**, which are more difficult to standardize than the criteria used in the RCRI. *Gupta Myocardial Infarction or Cardiac Arrest Calculator* - The **Gupta Calculator** (based on the NSQIP database) is a valid alternative but is not the primary clinical tool specifically emphasized in traditional **ACC/AHA preoperative guidelines**. - While it offers higher predictive accuracy for **perioperative MI**, it requires a web-based interface and includes **functional status** as a key variable. *Detsky Modified Multifactorial Index* - This index is a **modification of the Goldman Index** that includes variables like **angina class** and remote history of myocardial infarction. - It is utilized less frequently than the RCRI because it is more complex to calculate and has not shown superior **predictive value** in broad surgical populations.

Question 11: All of the following are contraindications to femoral vein phlebotomy, EXCEPT?

A. Venous occlusive disease of the extremities
B. Loss of sensation (Correct Answer)
C. Previous surgery of the knee
D. Acquired bleeding disorder

Explanation: **Explanation:** Femoral vein phlebotomy is a common procedure for obtaining venous access or blood samples when peripheral veins are inaccessible. Understanding the contraindications is vital for preventing complications like hematoma, thrombosis, or infection. **Why "Loss of Sensation" is the Correct Answer:** Loss of sensation (sensory neuropathy) is **not** a contraindication for femoral vein phlebotomy. In fact, it may make the procedure more tolerable for the patient as they will not feel the needle prick. Unlike arterial procedures where patient feedback regarding paresthesia is crucial to avoid nerve injury, venous puncture in a numb area does not pose an inherent risk to the patient’s safety or the success of the procedure. **Why the other options are Incorrect (Contraindications):** * **Venous Occlusive Disease (A):** If the femoral vein or the proximal iliac veins are occluded (e.g., DVT), phlebotomy is contraindicated as it is impossible to draw blood, and the procedure may dislodge a clot, leading to pulmonary embolism. * **Previous Surgery of the Knee (C):** This is a specific contraindication for femoral access on the **ipsilateral** side. Orthopedic surgeries (like Total Knee Arthroplasty) increase the risk of venous stasis and infection. Accessing the femoral vein in such patients carries a high risk of introducing infection into a prosthetic joint or triggering thrombosis. * **Acquired Bleeding Disorder (D):** Coagulopathies or the use of anticoagulants are relative to absolute contraindications. Because the femoral vein is deep and cannot be easily compressed against a bony prominence (unlike the radial artery), there is a high risk of uncontrollable retroperitoneal hemorrhage or massive hematoma. **High-Yield NEET-PG Pearls:** * **Anatomy (NAVEL):** From Lateral to Medial: Nerve, Artery, **V**ein, Empty space, Lymphatics. The vein is medial to the femoral artery pulse. * **Site of Puncture:** 1–2 cm below the inguinal ligament. * **Absolute Contraindication:** Overlying skin infection (cellulitis) at the site of puncture.

Question 12: Which of the following is the necessary pre-operative investigation which has to be done in a patient with Down's syndrome posted for surgery?

A. Echocardiography to assess congenital heart defects (Correct Answer)
B. Cervical spine X-Ray to evaluate atlantoaxial instability
C. Abdominal ultrasound to detect gastrointestinal anomalies
D. Brain CT scan to identify structural abnormalities

Explanation: ***Echocardiography to assess congenital heart defects*** - Patients with **Down syndrome (Trisomy 21)** have a high incidence of congenital heart defects, most commonly **atrioventricular septal defects**, which require evaluation prior to surgery due to their anesthetic and surgical implications. - Pre-surgical echocardiography is crucial to identify and characterize these defects, allowing for appropriate perioperative management and optimization of cardiac function. *Cervical spine X-Ray to evaluate atlantoaxial instability* - While **atlantoaxial instability** is a known concern in Down syndrome, particularly important for procedures involving neck manipulation, it is not universally necessary for *every* surgical patient. - Cervical spine imaging is typically reserved for elective procedures where neck manipulation is anticipated or if there are clinical signs suggestive of myelopathy. *Abdominal ultrasound to detect gastrointestinal anomalies* - Gastrointestinal anomalies like **duodenal atresia** or **Hirschsprung disease** are more prevalent in Down syndrome but are usually identified and treated in infancy or childhood due to symptomatic presentation. - Unless there are specific clinical symptoms or a history of unaddressed GI issues, a routine preoperative abdominal ultrasound is generally not indicated. *Brain CT scan to identify structural abnormalities* - Individuals with Down syndrome often have developmental brain differences, but a routine preoperative brain CT scan is not standard practice unless there are neurological symptoms or a history of conditions like seizures or hydrocephalus requiring investigation. - It would not be considered a necessary **pre-operative investigation** for general surgical fitness in the absence of specific indications.

Question 13: A patient posted for Lap Cholecystectomy had drug eluting stent placed two years back. Patient has no symptoms since then. Which of the following set of investigation should be done in this patient?

A. Coronary angiography, Thallium scan
B. ECG, CBC, Coronary angiography
C. ECG, CBC, Stress echocardiography (Correct Answer)
D. ECG, CBC, Stress echocardiography, coronary angiography

Explanation: **ECG, CBC, Stress echocardiography** - A patient with a **drug-eluting stent (DES)** placed two years prior, who is now asymptomatic, typically requires a **non-invasive cardiac assessment** before surgery. [1] - **Stress echocardiography** is an appropriate investigation to assess for inducible ischemia in an asymptomatic patient with a history of DES, especially when determining readiness for non-cardiac surgery. [1] *Coronary angiography, Thallium scan* - **Coronary angiography** is an invasive procedure and is generally not indicated for asymptomatic patients two years post-DES unless there are new symptoms or high-risk findings on non-invasive tests. [2] - A **Thallium scan** (myocardial perfusion scintigraphy) is a valid stress test, but **stress echocardiography** provides similar information regarding ischemia and ventricular function without radiation exposure. [1] *ECG, CBC, Coronary angiography* - While **ECG** and **CBC** are standard preoperative tests, **coronary angiography** is an invasive procedure and is not the first-line investigation for an asymptomatic patient two years post-DES without other indications. [2] - The patient's asymptomatic status suggests that invasive testing is not immediately warranted for surgical clearance. *ECG, CBC, Stress echocardiography, coronary angiography* - Performing both **stress echocardiography** and **coronary angiography** in an asymptomatic patient two years after DES placement is **redundant** and subjects the patient to an unnecessary invasive procedure. [1], [2] - The results of a non-invasive stress test like stress echocardiography would guide the need for any further invasive intervention.

Question 14: Most sensitive marker for post-transplant rejection of liver is:

A. GGT
B. AST
C. ALT (Correct Answer)
D. Bilirubin

Explanation: ***ALT*** - **Alanine aminotransferase (ALT)** is primarily found in the liver and is a highly sensitive indicator of **hepatocellular damage**. [1] - Elevations in ALT often precede other markers in cases of **acute cellular rejection** in liver transplant recipients. *GGT* - **Gamma-glutamyl transferase (GGT)** can be elevated in liver injury, but it is also increased in **biliary obstruction** and due to certain medications like alcohol. [1] - While GGT can be a general marker of liver stress, it is less specific than ALT for hepatocellular rejection. *AST* - **Aspartate aminotransferase (AST)** is found in the liver, heart, skeletal muscle, and kidneys, making it **less specific** to liver injury than ALT. - Although AST levels rise in liver damage, ALT is generally considered a more liver-specific enzyme. *Bilirubin* - **Bilirubin** levels primarily reflect the liver's ability to conjugate and excrete bilirubin, often indicating **cholestasis** or severe hepatocellular dysfunction. - While elevated bilirubin can occur with rejection, it is typically a **later and less sensitive marker** compared to transaminases for early hepatocellular rejection.

Question 15: A 72-year-old male with a history of coronary artery disease and a previous myocardial infarction is scheduled for an elective colectomy for a large adenomatous polyp. What perioperative cardiac evaluations and interventions are necessary to optimize surgical outcomes?

A. Cardiology consultation, stress testing, and possible coronary intervention are necessary. (Correct Answer)
B. Only routine blood tests.
C. Proceeding with surgery without further evaluation.
D. Considering the patient’s dietary preferences.

Explanation: ***Cardiology consultation, stress testing, and possible coronary intervention are necessary.*** * Given the patient's history of **coronary artery disease (CAD)** and a **previous myocardial infarction (MI)**, a comprehensive cardiac evaluation is crucial to assess perioperative risk. * A **cardiology consultation** can guide further testing like **stress testing** to identify inducible ischemia, and if indicated, **coronary intervention** may be needed to optimize cardiac status before elective surgery, reducing the risk of perioperative cardiac events. *Only routine blood tests.* * While routine blood tests are part of most pre-surgical evaluations, they are **insufficient** to assess the comprehensive cardiac risk in a patient with a significant history of CAD and MI. * Routine blood tests do not provide information on **myocardial ischemia**, ventricular function, or valvular disease, which are critical for surgical planning in this population. *Proceeding with surgery without further evaluation.* * This option is **unsafe** and could lead to severe perioperative cardiac complications, including MI, arrhythmia, or cardiac arrest, due to the patient's existing cardiac disease. * Elective surgery in a patient with known CAD and previous MI necessitates a thorough cardiac risk assessment to minimize morbidity and mortality. *Considering the patient’s dietary preferences.* * While dietary preferences are important for patient comfort and postoperative recovery, they are **not a primary perioperative cardiac intervention or evaluation** for a patient with established CAD and MI. * This information is secondary to ensuring cardiac stability and minimizing surgical risk.

Question 16: A 70-year-old man with chronic obstructive pulmonary disease (COPD) is scheduled for abdominal surgery. What is the most important preoperative consideration?

A. Pulmonary function tests
B. Smoking cessation (Correct Answer)
C. Bronchodilator therapy
D. Chest X-ray

Explanation: ***Smoking cessation*** - **Smoking cessation** for at least **6-8 weeks** prior to surgery significantly reduces postoperative pulmonary complications, especially in patients with **COPD** [1]. - This allows for improvement in mucociliary clearance, reduction in airway inflammation, and decreased sputum production [1]. *Pulmonary function tests* - While pulmonary function tests (PFTs) can provide a baseline assessment of lung function, they are **not the most important immediate preoperative intervention** to reduce risk. - PFTs help characterize the severity of COPD but do not directly mitigate surgical risk as much as smoking cessation. *Bronchodilator therapy* - **Optimizing bronchodilator therapy** is important for patients with COPD to improve airflow and reduce bronchospasm [1]. - However, it addresses ongoing symptoms rather than the fundamental inflammatory and secretory effects of smoking, making it less impactful than smoking cessation as the **most important single consideration**. *Chest X-ray* - A **chest X-ray** provides structural information about the lungs and can detect acute processes like pneumonia or effusions. - While useful for preoperative assessment, it is a diagnostic tool and does not actively modify the patient's physiological risk in the way that smoking cessation does.

Question 17: Monoclonal antibodies to the CD25 (IL-2α) receptors are used for the treatment of:

A. Kidney transplant rejection (Correct Answer)
B. Hematological malignancies
C. Autoimmune disorders
D. Bone marrow transplant complications

Explanation: ***Kidney transplant rejection*** - Monoclonal antibodies targeting **CD25 (IL-2α receptor)** interfere with T-cell activation and proliferation, which are critical in mediating transplant rejection [1], [2]. - Examples include **basiliximab** and **daclizumab**, which are used as induction therapy to prevent acute rejection in organ transplantation [2]. *Hematological malignancies* - While some monoclonal antibodies are used for hematological malignancies (e.g., rituximab for CD20), those targeting **CD25** are not primary treatments for most hematological cancers. - **CD25** can be expressed on some leukemias (e.g., hairy cell leukemia), but the main use of CD25 antibodies is in immunosuppression. *Autoimmune disorders* - Although immune activation is central to autoimmune diseases, specific **CD25-targeting antibodies** are not widely established as frontline treatments for most autoimmune disorders. - Other immunomodulators and biologics are more commonly used in this context. *Bone marrow transplant complications* - While some immunosuppressants are used to manage complications like **graft-versus-host disease (GVHD)**, agents specifically targeting **CD25** are not primary treatments for these complications. - GVHD treatment often involves corticosteroids and other broad immunosuppressants.

Question 18: What is the best treatment advice for a 69-year-old male patient with coronary artery disease and asymptomatic gallbladder stones, who has no history of biliary colic or jaundice?

A. Open cholecystectomy
B. Laparoscopic cholecystectomy
C. ERCP and removal of gallbladder stones
D. Observation without surgery for gallbladder stones (Correct Answer)

Explanation: ***Observation without surgery for gallbladder stones*** - For **asymptomatic gallbladder stones**, especially in patients with **coronary artery disease** (which increases surgical risk), observation is the recommended approach [1]. The risk of developing symptoms or complications (e.g., cholecystitis, cholangitis, pancreatitis) is low (1-2% per year), and the risks of surgery generally outweigh the benefits [1]. - Due to the patient's age (69 years) and existing **coronary artery disease**, avoiding elective surgery reduces the risk of perioperative cardiac events and other surgical complications. *Open cholecystectomy* - This is an **invasive surgical procedure** with higher risks of postoperative pain, infection, and longer recovery compared to laparoscopic cholecystectomy. - It is generally reserved for complicated cases or when laparoscopic surgery is contraindicated, which is not indicated here given the asymptomatic nature of the stones. *Laparoscopic cholecystectomy* - While less invasive than over surgery, it is still a **surgical procedure carrying inherent risks**, including those related to general anesthesia and potential complications like bile duct injury or bleeding. - Elective surgery for asymptomatic gallstones is generally not recommended as the potential benefits do not outweigh the procedural risks, especially in a patient with significant comorbidities like **coronary artery disease**. *ERCP and removal of gallbladder stones* - **ERCP (Endoscopic Retrograde Cholangiopancreatography)** is a procedure primarily used to visualize and address issues within the bile ducts and pancreatic duct, such as common bile duct stones. - It is **not used for removing stones directly from the gallbladder** itself and is an invasive procedure with risks like pancreatitis, perforation, and bleeding, making it inappropriate for asymptomatic gallbladder stones.

Practice by Chapter

Preoperative Evaluation

Practice Questions

Risk Assessment and Stratification

Practice Questions

Perioperative Medication Management

Practice Questions

Cardiac Risk in Non-cardiac Surgery

Practice Questions

Pulmonary Risk Assessment

Practice Questions

Venous Thromboembolism Prophylaxis

Practice Questions

Postoperative Complications

Practice Questions

Perioperative Antibiotic Prophylaxis

Practice Questions

Special Population Considerations

Practice Questions

Perioperative Pain Management

Practice Questions

Postoperative Delirium Prevention

Practice Questions

Enhanced Recovery Protocols

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free